Case number 1:17-cv-00816
Amgen Inc. v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (9) |
| Apr 23, 2018 | 31 | Patent/Trademark Report to Commissioner (4) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) |
| Apr 23, 2018 | 30 | SO ORDERED (3) Docket Text: SO ORDERED - re [29] Stipulation of Dismissal (between Plaintiff and Lupin Defendants) filed by Amgen Inc.. Signed by Judge Gregory M. Sleet on 4/23/2018. ***Civil Case Terminated*** (mdb) |
| Apr 19, 2018 | 29 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal (between Plaintiff and Lupin Defendants) by Amgen Inc.. (Blumenfeld, Jack) Modified on 4/19/2018 (mdb). |
| Feb 1, 2018 | 28 | Order (3) Docket Text: ORDER On or before March 1, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in this Order. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/1/18. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(cak) |
| Dec 13, 2017 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Proposed Scheduling Order filed on 12/11/2017 has been replaced to correct the language in the settlement conference paragraph. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(mdb) |
| Dec 13, 2017 | N/A | Remark (0) Docket Text: Remark - These cases have been consolidated for ALL PURPOSES. All future filings will be made ONLY in Lead C.A. No. 17-815-GMS. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(mdb) |
| Dec 11, 2017 | 27 | Proposed Order (6) |
| Dec 11, 2017 | 27 | Letter to The Honorable Gregory M. Sleet from M. Noreika enclosing order (1) |
| Dec 11, 2017 | 27 | Main Document (6) Docket Text: PROPOSED ORDER -- Scheduling Order -- by Amgen Inc.. (Attachments: # (1) Letter to The Honorable Gregory M. Sleet from M. Noreika enclosing order)(Noreika, Maryellen) (Main Document 27 replaced on 12/13/2017) (mdb). |
| Dec 8, 2017 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupins Initial Invalidity Contentions filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Murphy, Francis) |
| Nov 29, 2017 | 25 | Transcript (24) Docket Text: Official Transcript of Conference held on 11 20 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/20/2017. Redacted Transcript Deadline set for 1/2/2018. Release of Transcript Restriction set for 2/27/2018. (kjm) |
| Nov 20, 2017 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 11/20/2017. Discussion regarding the contents and differences in the joint status report. The Sherman Antitrust Act counterclaims are STAYED pending resolution of the patent claims. These cases will be consolidated for all purposes, including trial. A 5-day bench trial is set for 4/29/2019 at 9:00 AM in Courtroom 4A, and a Markman Hearing (1/2 day) is set for 4/2/2018 at 9:30 AM in Courtroom 4A, unless otherwise notified by the parties. The defendants will consult with their clients and inform the court, via the proposed amended scheduling order, if the Markman Hearing is necessary. The proposed amended scheduling order is due by 12/11/2017. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-00817-GMS, 1:17-cv-00815-GMS, 1:17-cv-00816-GMS(mdb) |
| Nov 9, 2017 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (14 in 1:17-cv-00815-GMS, 20 in 1:17-cv-00816-GMS, 39 in 1:17-cv-00817-GMS) Joint Status Report - A Scheduling Conference is set for Monday, November 20, 2017 at 10:00 AM in Courtroom 4A. Ordered by Judge Gregory M. Sleet on 11/9/2017. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS(mdb) |
| Nov 3, 2017 | 24 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions Regarding Lupin filed by Amgen Inc..(Noreika, Maryellen) |
| Oct 25, 2017 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Service of 4(b) Disclosure filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Murphy, Francis) |
| Oct 19, 2017 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Rule 26(a)(1) Initial Disclosures; and (2) Defendants Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Murphy, Francis) |
| Oct 18, 2017 | 21 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Rule 26(a)(1) Initial Disclosures to Lupin; (2) Plaintiff's Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 to Lupin; and (3) Plaintiff's Default Standard Paragraph 4(a) Disclosures to Lupin filed by Amgen Inc..(Noreika, Maryellen) |
| Oct 11, 2017 | 20 | Status Report (25) Docket Text: Joint STATUS REPORT by Amgen Inc.. (Noreika, Maryellen) |
| Oct 4, 2017 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file Joint Status Report to October 11, 2017 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis) |
| Oct 4, 2017 | N/A | SO ORDERED (0) |
| Sep 21, 2017 | N/A | SO ORDERED (0) |
| Sep 20, 2017 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report to October 4, 2017 - filed by Amgen Inc.. (Noreika, Maryellen) |
| Aug 21, 2017 | 17 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 8/21/2017. (asw) |
| Aug 15, 2017 | 16 | Answer to Counterclaim (5) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Amgen Inc..(Noreika, Maryellen) Modified on 8/16/2017 (mdb). |
| Aug 9, 2017 | N/A | SO ORDERED (0) |
| Aug 9, 2017 | 15 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for plaintiff to move, answer, or otherwise respond to defendants' counterclaim to August 15, 2017 - filed by Amgen Inc.. (Noreika, Maryellen) |
| Aug 8, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy F. Peterson for Lupin Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Aug 8, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 7, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 4, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 3, 2017 | 14 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Scott Feder - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis) |
| Aug 3, 2017 | 13 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Timothy F. Peterson - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis) |
| Aug 3, 2017 | 12 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis) |
| Aug 3, 2017 | 11 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Carolyn A. Blessing - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Murphy, Francis) |
| Aug 3, 2017 | N/A | SO ORDERED (0) |
| Jul 19, 2017 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Atlantis Holdings S.A., Corporate Parent Lupin Inc. for Lupin Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc. filed by Lupin Pharmaceuticals, Inc.. (Murphy, Francis) |
| Jul 19, 2017 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Ltd.. (Murphy, Francis) |
| Jul 19, 2017 | 8 | Answer to Complaint (22) Docket Text: ANSWER to [1] Complaint, First Counterclaim Declaration of Noninfringement of the 405 Patent: Second Counterclaim Declaration of Invalidity of the 405 Patent against Amgen Inc. by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Murphy, Francis) Modified on 7/20/2017 (mdb). |
| Jun 29, 2017 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc.. Lupin Pharmaceuticals, Inc. served on 6/28/2017, answer due 7/19/2017. (Blumenfeld, Jack) |
| Jun 29, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc.. Lupin Ltd. served on 6/28/2017, answer due 7/19/2017. (Blumenfeld, Jack) |
| Jun 28, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-00815-GMS, 1:17-cv-00816-GMS, 1:17-cv-00817-GMS (rjb) |
| Jun 23, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Ltd. on 6/26/2017; Lupin Pharmaceuticals, Inc. on 6/26/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Jun 23, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc. (nmg) |
| Jun 23, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,405 B2. (nmg) |
| Jun 23, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/12/2017. Date of Expiration of Patent: 9/22/2026. (nmg) |
| Jun 23, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jun 23, 2017 | 1 | Civil Cover Sheet (1) |
| Jun 23, 2017 | 1 | Main Document (9) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2170202.) - filed by Amgen Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Jun 23, 2017 | 1 | Exhibit A (14) |
| Jun 23, 2017 | 1 | Complaint* (1) |
